Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 860-695-9 | CAS number: 88247-41-0
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Acute Toxicity: oral
Administrative data
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 09 Mar - 01 Apr 2021
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 021
- Report date:
- 2021
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 423 (Acute Oral toxicity - Acute Toxic Class Method)
- Version / remarks:
- adopted in 2001
- Deviations:
- no
- GLP compliance:
- yes
- Test type:
- acute toxic class method
- Limit test:
- no
Test material
- Reference substance name:
- N,N-bis(2-ethylhexyl)formamide
- EC Number:
- 860-695-9
- Cas Number:
- 88247-41-0
- Molecular formula:
- C17H35NO
- IUPAC Name:
- N,N-bis(2-ethylhexyl)formamide
- Test material form:
- liquid
Constituent 1
Test animals
- Species:
- rat
- Strain:
- other: Crl:CD(SD)
- Sex:
- female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Hino Breeding Center, Charles River Laboratories, Japan
- Age at study initiation: 7 weeks
- Weight at study initiation: 191.3 - 216.7 g
- Fasting period before study: From 18 h before administration to 3 h after administration.
- Housing: In groups of 3/cage during the quarantine period and acclimatisation and individually thereafter. The animals were kept in hanging stainless steel cages with mesh-floor (260W x 380D x 180H mm) before the group allocation and in hanging stainless steel cages with mesh-floor (165W x 300Dx 150H mm) after the group allocation.
- Historical data: Historical control data comprising clinical signs, body weight and necropsy data were available for animals administered the vehicle (olive oil).
- Diet: pelleted diet MF (Lots 201008 and 201214, Oriental Yeast), ad libitum, autoclaved before use
- Water: chlorinated water (sodium hypochlorite was added at 3 - 5 ppm to maintain the chloric level), ad libitum
- Acclimation period: 6 days
- Microbiological status when known : SPF
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 21 - 25
- Humidity (%): 40 - 70
- Air changes (per hr): 10 - 15
- Photoperiod (hrs dark / hrs light): 12 / 12
IN-LIFE DATES: From: 02 Mar 2021 To: 01 Apr 2021
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- olive oil
- Details on oral exposure:
- VEHICLE
- Concentration in vehicle: 3 and 20% (w/v)
- Amount of vehicle: 10 mL/kg bw
- Justification for choice of vehicle: Although the test substance did not dissolve and was not suspended to purified water at a concentration of 20.0 w/v%, the test substance was dissolved to olive oil at a concentration of 20.0 w/v%. The condition of the formulation such as color did not change at room temperature four hours after the preparation. Therefore, olive oil was selected as a vehicle.
MAXIMUM DOSE VOLUME APPLIED: 10 mL/kg bw
DOSAGE PREPARATION:
Dosing formulation was prepared on each administration day. The test substance was weighed and mixed with olive oil to be dissolved. The solution was filled up to the prescribed volume with olive oil to prepare the dosing formulation. The dosing formulation was carried to the animal room.
CLASS METHOD:
- Rationale for the selection of the starting dose: Since no toxic information of the test substance was available, the dose level of the 1st step was set at 300 mg/kg bw. Subsequent doses were set according to the test method. - Doses:
- 300 and 2000 mg/kg bw
- No. of animals per sex per dose:
- 3 females per step per dose group
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations: In each step, the animals were observed continuously for 10 min after the administration, and observed 30 min and 3 h after the administration on the administration day, and animals were observed once in the morning from 1 - 14 days after the administration.
- Frequency of weighing: Body weights were recorded prior to administration (Day 0) and on Days 1, 7 and 14 after administration.
- Necropsy of survivors performed: The animals were subjected to a gross necropsy 14 days after the administration. The animals were euthanized by bleeding from the abdominal aorta under isoflurane anesthesia. External surface of the body, all orifices, subcutis, cranial, thoracic, abdominal and pelvic cavities with their contents were observed. - Statistics:
- Statistical analysis was not performed.
Results and discussion
Effect levels
- Key result
- Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- > 2 000 mg/kg bw
- Based on:
- test mat.
- Mortality:
- No mortality occurred during the study period.
- Clinical signs:
- other: 300 mg/kg bw (1st and 2nd step): 2/6 animals showed mucous stool 3 h after administration. The animals fully recovered within 24 h post administration. There were no abnormalities observed thereafter. 2000 mg/kg bw (3rd and 4th step): No clinical signs of
- Gross pathology:
- Necropsy and pathological examination revealed no substance-related findings.
Any other information on results incl. tables
Table 1: Body weight development
Step | Dose (mg/kg) | Animal No. | Body weights (g) | |||
Day after administration | ||||||
Initial | 1 | 7 | 14 | |||
1st | 300 | 1 | 197.2 | 218.8 | 240.1 | 252.1 |
ΔBW | 21.6 | 21.3 | 12.0 | |||
2 | 191.3 | 204.8 | 234.7 | 254.6 | ||
ΔBW | 13.5 | 29.9 | 19.9 | |||
3 | 197.6 | 217.8 | 245.5 | 264.9 | ||
ΔBW | 20.2 | 27.7 | 19.4 | |||
2nd | 4 | 199.7 | 222.4 | 239.3 | 251.5 | |
ΔBW | 22.7 | 16.9 | 12.2 | |||
5 | 201.2 | 223.8 | 253.5 | 260.7 | ||
ΔBW | 22.6 | 29.7 | 7.2 | |||
6 | 203.3 | 222.1 | 253.7 | 280.7 | ||
ΔBW | 18.8 | 31.6 | 27.0 | |||
3rd | 2000 | 7 | 216.7 | 215.9 | 246.6 | 266.6 |
ΔBW | -0.8 | 30.7 | 20.0 | |||
8 | 211.3 | 223.5 | 252.0 | 271.6 | ||
ΔBW | 12.2 | 28.5 | 19.6 | |||
9 | 212.4 | 218.1 | 264.2 | 307.8 | ||
ΔBW | 5.7 | 46.1 | 43.6 | |||
4th | 10 | 213.0 | 217.0 | 248.5 | 263.5 | |
ΔBW | 4.0 | 31.5 | 15.0 | |||
11 | 209.9 | 220.1 | 248.1 | 249.2 | ||
ΔBW | 10.2 | 28.0 | 1.1 | |||
12 | 209.7 | 216.9 | 237.0 | 249.2 | ||
ΔBW | 7.2 | 20.1 | 12.2 | |||
Historical control data (n = 30) | mean ± SD | 16.3 ± 4.2 | ||||
Range | 7.4 - 27.9 | |||||
ΔBW: Difference from previous body weight |
Applicant's summary and conclusion
- Interpretation of results:
- other: CLP/EU GHS criteria not met, no classification required according to Regulation (EC) No. 1272/2008
- Conclusions:
- The substance was tested for acute oral toxicity in female rats according to OECD guideline 423, at dose levels of 300 and 2000 mg/kg bw. No mortality occured and the resulting LD50 was > 2000 mg/kg bw.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.